ARX Equity Partners related stories
All articles and analysis
Three homegrown LPs making their mark in Central and Eastern EuropeLocal investor groups are increasingly more visible and competing for deals with private equity firms.
CEE-focused funds break fundraising record – reportFunding from non-European investors accounted for close to 40 percent of total commitments for the region in 2018, according to a report from Invest Europe.
Exit File: emerging markets CEEA key recent deal from the region.
Just Closed: ARX Equity Partners holds first closeThe EIF is a limited partner in the fund.
- ARX slims fund on narrowed geographic focus
The Czech-focused firm is looking to raise €100m, down from €125 million, for its latest fund that is no longer targeting investments in Poland.
- ARX seals Slovenian healthcare deal
The investment comes as ARX is planning to raise €125m for its latest fund
- ARX backs Hungarian bottle maker
The deal comes as ARX prepares to come to market with a successor fund.
- CVCI in €365m pharma exit
The private equity arm of Citi Capital Advisors has agreed to sell specialty pharmaceutical company Sanitas to Valeant Pharmaceuticals.
- Why Poland is top of the league
Central and Eastern Europe offers some intriguing opportunities. Tim Chapman tells good from bad
- Arx inches closer to €125m final close
The lower mid-market firm has held a €102m second close on its third CEE-focused fund.